1. A clinical trial for compassionate use of NHWD-870 in patients with advanced solid tumors or lymphomas carrying NUT rearrangement is recruiting participants (all ages welcome).
2. A multicenter, open-label, single-arm, phase II clinical study on the treatment of advanced NUT carcinoma in adults and adolescents with NHWD-870 HCl is recruiting participants (Part 1 limited to ages 18 and above; Part 2 limited to ages 12-18).